Scribd
Upload
79 views1 page

Diabetes Management and Treatment Plan

The patient has type 2 diabetes mellitus complicated by neuropathy, hypertension stage II, dyslipidemia, and obesity. The document outlines a treatment plan including oral or topical agents for neuropathy pain, medications to control nausea, individualized glycemic control, comprehensive cardiovascular risk management, and lifestyle modifications. Regular monitoring by a primary care physician is recommended to assess symptoms and modify therapy.

Uploaded by

angel23
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
79 views1 page

Diabetes Management and Treatment Plan

The patient has type 2 diabetes mellitus complicated by neuropathy, hypertension stage II, dyslipidemia, and obesity. The document outlines a treatment plan including oral or topical agents for neuropathy pain, medications to control nausea, individualized glycemic control, comprehensive cardiovascular risk management, and lifestyle modifications. Regular monitoring by a primary care physician is recommended to assess symptoms and modify therapy.

Uploaded by

angel23
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Problem Lists Patient Plan

Diabetes Mellitus  (T/C DM-related neuropathy)


Diabetes Mellitus  (T/C DM-related neuropathy) (EASD/ADA, 2019) 
 Give oral agents or topical therapy  (if the
 untolerated body weakness; pain patient cannot tolerate oral medication)
 loss of appetite for diabetic neuropathy pain. 
 nausea  Give medications to control nausea
 dysphagia in solid food induced by gastroparesis (Mayo Clinic,
 numbness 2020) 
 polyuria  Perform individualized glycemic targets
 polydipsia (excessive thirst or hunger) and glucose-lowering therapies that have
 weight loss evidence for cardiorenal benefit.  (strict
 BMI: 33.6 Obese (Asia classification: glycemic control reduces development of
Obese; Obese Class I WHO neurological abnormalities) 
classification)  Comprehensive cardiovascular risk factor
management by cardiac risk reduction
Hypertension Stage II
Hypertension Stage II (ISH,
 displaced apex beat (6th LICS MAL, 2020)
according to Harrison’s Principle of o Control and monitoring
Medicine, 2018)
blood pressure, lowered
 elevated blood pressure of 140-150/80- to a target of <130/80
100 mmHg) mmHg Reduce risk of
 BMI: 33.6 Obese (Asia classification: CVD and target organ
Obese; Obese Class I WHO damage by giving
classification) antihypertensive agents
(strategy should include
Dyslipidemia RAS inhibitor + CCB/
 BMI: 33.6 Obese (Asia classification: thiazide-like diuretics)  in
Obese; Obese Class I WHO consideration with
classification) glucose and  lipid
lowering benefits
 Missing Data: o For patients with DM and
HTN, Serum triglyceride
 Glucose panel should be lowered to
>200mg/dL 
 Serum lipid profile panel (Total o Monitor adherence
cholesterol, HDL-C, and LDL levels) antihypertensive
 CBC panel treatment 
 Electrocardiogram  Intensive treatment education and lifestyle
Pain Assessment (OLDCARTS)) modification (smoking cessation,
implement Medical nutrition therapy
(MNT) for diet plan, regular physical
activity, moderation of alcohol intake) 
 Regular monitoring by a primary care
physician every 4 weeks to 3 months to
assess improvement of pain, and nausea
and modify therapy if needed.

You might also like